These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15372473

  • 1. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.
    Couriel D, Caldera H, Champlin R, Komanduri K.
    Cancer; 2004 Nov 01; 101(9):1936-46. PubMed ID: 15372473
    [Abstract] [Full Text] [Related]

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A.
    Biol Blood Marrow Transplant; 2005 May 01; 11(5):389-98. PubMed ID: 15846293
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Life-threatening graft-vs-host disease.
    Vargas-Díez E, García-Díez A, Marín A, Fernández-Herrera J.
    Clin Dermatol; 2005 May 01; 23(3):285-300. PubMed ID: 15896544
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Socié G, Golmard JL, Jouet JP, French Society of Bone Marrow Transplantation and Cell Therapy.
    J Clin Oncol; 2006 Dec 20; 24(36):5695-702. PubMed ID: 17116940
    [Abstract] [Full Text] [Related]

  • 10. Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients.
    Deeg HJ.
    Bone Marrow Transplant; 1994 Dec 20; 14 Suppl 4():S56-60. PubMed ID: 7728127
    [Abstract] [Full Text] [Related]

  • 11. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE, van der Holt B, Haze S, Braakman E, Gratama JW, Löwenberg B, Cornelissen JJ.
    Exp Hematol; 2005 Aug 20; 33(8):912-9. PubMed ID: 16038784
    [Abstract] [Full Text] [Related]

  • 12. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M, Hatanaka K, Tanimoto M, Harada M, Nakao S, Abe Y, Wake A, Eto T, Takemoto Y, Imamura M, Takahashi S, Ishida Y, Kanda Y, Kasai M, Takaue Y.
    Br J Haematol; 2005 Aug 20; 130(4):575-87. PubMed ID: 16098073
    [Abstract] [Full Text] [Related]

  • 13. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Schmitz M, Fischer J, Göbel U, Enczmann J, Dilloo D.
    Biol Blood Marrow Transplant; 2007 Nov 20; 13(11):1338-45. PubMed ID: 17950920
    [Abstract] [Full Text] [Related]

  • 14. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA, Carter SL, Freifeld AG, High KP, Godder KT, Papanicolaou GA, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA.
    Biol Blood Marrow Transplant; 2007 Dec 20; 13(12):1487-98. PubMed ID: 18022579
    [Abstract] [Full Text] [Related]

  • 15. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C, Schirutschke H, Ehninger G, Bornhäuser M, Platzbecker U.
    Clin Cancer Res; 2007 May 15; 13(10):2916-22. PubMed ID: 17504991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N, Chamakhi I, Perreault C, Roy DC, Sauvageau G, Ducruet T, Busque L, Fish D, Bélanger R, Roy J.
    Exp Hematol; 2006 Jan 15; 34(1):107-14. PubMed ID: 16413397
    [Abstract] [Full Text] [Related]

  • 18. Graft-versus-host disease: emerging concepts in prevention and therapy.
    Dean RM, Bishop MR.
    Curr Hematol Rep; 2003 Jul 15; 2(4):287-94. PubMed ID: 12901325
    [Abstract] [Full Text] [Related]

  • 19. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
    Wang Y, Chen F, Han Y, Fu ZZ, Tang XW, Miao M, Qiu HY, Jin ZM, Sun AN, Wu DP.
    Biol Blood Marrow Transplant; 2009 Oct 15; 15(10):1258-64. PubMed ID: 19747633
    [Abstract] [Full Text] [Related]

  • 20. Prophylaxis and treatment of acute graft-versus-host disease.
    Chao NJ, Chen BJ.
    Semin Hematol; 2006 Jan 15; 43(1):32-41. PubMed ID: 16412787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.